Rosacea is significantly associated with dementia, particularly Alzheimer’s disease (AD). However, the common underlying molecular mechanism connecting these two diseases remains limited. This study aimed to reveal the common molecular regulatory networks and identify the potential therapeutic drugs for rosacea and AD. There were 747 overlapped DEGs (ol-DEGs) that were detected in AD and rosacea, enriched in inflammation-, metabolism-, and apoptosis-related pathways. Using the TF regulatory network analysis, 37 common TFs and target genes were identified as hub genes. They were used to predict the therapeutic drugs for rosacea and AD using the DGIdb/CMap database. Among the 113 predicted drugs, melatonin (MLT) was co-associated with both RORA and IFN-γ in AD and rosacea. Subsequently, network pharmacology analysis identified 19 pharmacological targets of MLT and demonstrated that MLT could help in treating AD/rosacea partly by modulating inflammatory and vascular signaling pathways. Finally, we verified the therapeutic role and mechanism of MLT on rosacea in vivo and in vitro. We found that MLT treatment significantly improved rosacea-like skin lesion by reducing keratinocyte-mediated inflammatory cytokine secretion and repressing the migration of HUVEC cells. In conclusion, this study contributes to common pathologies shared by rosacea and AD and identified MLT as an effective treatment strategy for rosacea and AD via regulating inflammation and angiogenesis.
Noninvasive electrocardiographic imaging, such as the reconstruction of myocardial transmembrane potentials (TMPs) distribution, can provide more detailed and complicated electrophysiological information than the body surface potentials (BSPs). However, the noninvasive reconstruction of the TMPs from BSPs is a typical inverse problem. In this study, this inverse ECG problem is treated as a regression problem with multi-inputs (BSPs) and multioutputs (TMPs), which will be solved by the Maximum Margin Clustering- (MMC-) Support Vector Regression (SVR) method. First, the MMC approach is adopted to cluster the training samples (a series of time instant BSPs), and the individual SVR model for each cluster is then constructed. For each testing sample, we find its matched cluster and then use the corresponding SVR model to reconstruct the TMPs. Using testing samples, it is found that the reconstructed TMPs results with the MMC-SVR method are more accurate than those of the single SVR method. In addition to the improved accuracy in solving the inverse ECG problem, the MMC-SVR method divides the training samples into clusters of small sample sizes, which can enhance the computation efficiency of training the SVR model.
Trajectory representation model has been proposed to describe non-rigid deformation. An optimal trajectory space finding algorithm for 3D non-rigid structure from motion (OTSF-NRSFM) based on this model also has been proposed. However, the influence of the wavelet basis selection on the OTSF-NRSFM algorithm has still not been studied. To help OTSF-NRSFM researchers select wavelet basis properly, we investigated the influences of wavelet basis selection. Two typical wavelet bases, DCT basis and WHT basis, are discussed in this paper. The spectrum properties of wavelet basis and feature point trajectory, trajectory representation results on synthetic shark data, OTSF-NRSFM reconstruction results on synthetic data and real data are analyzed. The results show that the wavelet selection has much influence on OTSF-NRSFM reconstruction results of some non-rigid feature points, which have complicated trajectory. This paper gives researchers some inspiration about wavelet basis selection in OTSF-NRSFM algorithm.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.